Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Allovir Inc (ALVR)  
$0.80 0.03 (3.5%) as of 4:30 Tue 5/21


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 61,660,000
Market Cap: 49.07(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6394 - $5.82
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   AlloVir is a late clinical-stage cell therapy company developing allogeneic T-cell therapies to treat and prevent devastating viral diseases. Co.'s Pipeline includes: Posoloeucel, which is an allogeneic, off-the-shelf virus-specific T cell (VST) therapy candidate targeting adenovirus, BK virus, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6 and JC virus that can lead to devastating viral disease in the allogeneic hematopoietic cell transplant population; and ALVR106, which is an allogeneic, off-the-shelf VST therapy candidate developed to target devastating diseases caused by human metapneumovirus, influenza, parainfluenza virus and respiratory syncytial virus.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 2,930,870 2,930,870
Total Buy Value $0 $0 $10,990,763 $10,990,763
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 37,487 181,676 258,494 1,542,385
Total Sell Value $29,070 $127,826 $332,564 $10,118,767
Total People Sold 4 4 4 7
Total Sell Transactions 15 34 58 106
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 288
  Page 6 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Atillasoy Ercem See Remarks   •       –      –    2022-07-21 4 S $5.38 $8,245 D/D (1,533) 133,467 -41%     
   Hallal David Director   –       •       •   2022-07-21 4 AS $5.33 $22,528 D/D (4,227) 2,073,662 41%     
   Sinha Vikas See Remarks   •       •      –    2022-07-20 4 S $5.21 $7,467 D/D (1,432) 938,224 -41%     
   Van Beek Jeroen B Chief Commercial Officer   •       –      –    2022-07-20 4 S $5.21 $5,517 D/D (1,058) 401,953 -41%     
   Atillasoy Ercem See Remarks   •       –      –    2022-07-20 4 S $5.21 $2,936 D/D (563) 135,000 -41%     
   Leen Ann M. Chief Scientific Officer   •       –      –    2022-07-01 4 A $0.00 $0 D/D 14,000 65,256     -
   Brainard Diana Chief Executive Officer   •       •      –    2022-07-01 4 A $0.00 $0 D/D 48,125 542,112     -
   Van Beek Jeroen B Chief Commercial Officer   •       –      –    2022-07-01 4 A $0.00 $0 D/D 14,000 403,011     -
   Hagen Brett R Chief Accounting Officer   •       –      –    2022-07-01 4 A $0.00 $0 D/D 10,500 93,578     -
   Atillasoy Ercem See Remarks   •       –      –    2022-07-01 4 A $0.00 $0 D/D 14,000 135,563     -
   Sinha Vikas See Remarks   •       •      –    2022-07-01 4 A $0.00 $0 D/D 29,400 939,656     -
   Miller Edward General Counsel   •       –      –    2022-07-01 4 A $0.00 $0 D/D 14,000 234,930     -
   Van Beek Jeroen B Chief Commercial Officer   •       –      –    2022-06-03 4 S $3.63 $1,871 D/D (515) 389,011 -144%     
   Hallal David Director   –       •       •   2022-06-03 4 AS $3.67 $241,106 D/D (65,725) 2,077,889 144%     
   Brainard Diana Chief Executive Officer   •       •      –    2022-05-18 4 S $4.33 $126,257 D/D (29,135) 492,165 -93%     
   Van Beek Jeroen B Chief Commercial Officer   •       –      –    2022-05-17 4 S $4.40 $67,167 D/D (15,262) 389,526 -72%     
   Bornstein Jeffrey S Director   –       •      –    2022-04-26 4 B $4.64 $23,197 D/D 5,000 40,197 2.39 54%     
   Atillasoy Ercem See Remarks   •       –      –    2022-04-21 4 S $5.86 $9,301 D/D (1,587) 121,563 -39%     
   Hallal David Director   –       •       •   2022-04-21 4 AS $5.87 $24,812 D/D (4,227) 2,143,614 39%     
   Sinha Vikas See Remarks   •       •      –    2022-04-20 4 S $6.68 $7,767 D/D (1,162) 906,633 -0%     
   Atillasoy Ercem See Remarks   •       –      –    2022-04-20 4 S $6.68 $3,028 D/D (453) 123,150 -0%     
   Van Beek Jeroen B Chief Commercial Officer   •       –      –    2022-04-20 4 S $6.68 $5,695 D/D (852) 404,788 -0%     
   Hagen Brett R Chief Accounting Officer   •       –      –    2022-04-20 4 S $6.68 $1,845 D/D (276) 80,368 -0%     
   Hallal David Director   –       •       •   2022-03-11 4 AS $7.37 $186,068 D/D (25,244) 2,147,841 -27%     
   Hallal David Director   –       •       •   2022-03-10 4 AS $7.55 $305,781 D/D (40,481) 2,173,085 -30%     
  288 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us